| Annual · values | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -400232 USD | -414045 USD | — |
| Depreciation & Amortization | — | — | — |
| Stock-Based Compensation | — | — | — |
| Capital Expenditures | — | — | — |
| Cash Flow from Investing | — | — | — |
| Cash Flow from Financing | — | — | — |
| Dividends Paid | — | — | — |
| Stock Buybacks | — | — | — |
| Free Cash Flow | -1.04 M USD | -697868 USD | — |
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. Deep Medicine Acquisition Corp. was incorporated in 2020 and is based in New York, New York. Deep Medicine Acquisition Corp. operates as subsidiary of Bright Vision Sponsor LLC.